Time to reconsider the role of ribavirin in Lassa fever.
Salam, Alex Paddy;
Cheng, Vincent;
Edwards, Tansy;
Olliaro, Piero;
Sterne, Jonathan;
Horby, Peter;
(2021)
Time to reconsider the role of ribavirin in Lassa fever.
PLoS neglected tropical diseases, 15 (7).
e0009522-.
ISSN 1935-2727
DOI: https://doi.org/10.1371/journal.pntd.0009522
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation of ribavirin is therefore needed.